Advancements in Tuberculosis and Lung Diseases

TB Clinical Trials

Clinical trials focus on diagnosing and treating tuberculosis, with efforts to develop more effective, tolerable, and shorter-duration treatment regimens. Projects include rapid urine-based TB screening in Africa and community-based TB testing and counseling initiatives.

TB clinical trials aim to develop novel diagnostics, drugs, and treatment regimens to combat tuberculosis. Recent advances focus on shorter, more effective regimens with improved tolerability. Trials evaluate new drugs, combinations, and treatment durations, aiming to optimize outcomes while reducing drug resistance. Initiatives explore innovative approaches such as host-directed therapies and immunotherapies to enhance treatment efficacy. Community-based trials target high-burden regions, emphasizing patient-centered care and addressing local challenges. Key projects include rapid screening methods, mass treatment plans, and interventions targeting TB-HIV co-infection. Clinical research partnerships facilitate collaboration between academia, industry, and public health sectors, accelerating progress towards global TB control and eradication.